AngioDynamics has commenced a post-market registry study of its Auryon atherectomy system, a laser technology platform designed for treating re-stenotic, de novo and in-stent restenosis lesions in infrainguinal arteries. The multicenter trial will follow for 36 months 100 patients with peripheral artery diseases who received treatment with the system.
AngioDynamics announces launch of atherectomy system trial
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.